Covid-19 roundup: Bi­va­lent vac­cines to be au­tho­rized by La­bor Day — re­port; Mod­er­na knocks on FDA's door for boost­ers

The Ad­vi­so­ry Com­mit­tee on Im­mu­niza­tion Prac­tices, which com­pris­es pub­lic health ex­perts who de­vel­op rec­om­men­da­tions on the use of vac­cines, is all set to hold two-day meet­ings next week to dis­cuss Covid-19 vac­cine boost­er dos­es, ac­cord­ing to a CBS News re­port. If all goes ac­cord­ing to plan, the bi­va­lent shots should be au­tho­rized and avail­able to the pub­lic by La­bor Day.

If the pan­el gives the thumbs-up, both Mod­er­na and Pfiz­er/BioN­Tech’s shots will be avail­able in the US for the gov­ern­ment’s fall vac­ci­na­tion cam­paign.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER